Telehealth Startups Shift to Older Diabetes Drug After FDA Blocks Off-Brand Ozempic Sales

Following the FDA's prohibition on the sale of Ozempic and Zepbound alternatives, telehealth companies have started prescribing liraglutide, a previously available GLP-1 drug that requires daily injections instead of weekly ones.